The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing

Weidong Li1, Xuejun Jin1, Xubin Deng1

  • 1Department of Medical Oncology, Affiliated Cancer Hospital of Guangzhou Medical University, Cancer Center of Guangzhou Medical University (CCGMU), Guangzhou, People's Republic of China.

Insights

MicroRNA-497 (miR-497) acts as a tumor suppressor in gastric cancer (GC) by inhibiting cell proliferation and invasion. Restoring miR-497 levels may offer a new therapeutic strategy for GC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play critical roles in gastric cancer (GC) pathogenesis.
  • The specific function of miR-497 in GC development and its underlying mechanisms are not well understood.

Purpose of the Study:

  • To investigate the role and mechanism of miR-497 in gastric cancer progression.
  • To determine if miR-497 functions as a tumor suppressor or oncogene in GC.

Main Methods:

  • Analysis of miR-497 expression in GC tissues and correlation with clinicopathological features.
  • In vitro studies assessing the effects of miR-497 on GC cell proliferation and invasion.
  • In vivo experiments to evaluate the impact of miR-497 on tumor growth and metastasis.
  • Luciferase assays, qRT-PCR, and Western blot to identify and validate miR-497 targets.

Main Results:

  • miR-497 was frequently downregulated in GC tissues and associated with aggressive features.
  • Enforced miR-497 expression inhibited GC cell proliferation (G1/S transition block) and invasion.
  • Restoration of miR-497 suppressed tumor growth and metastasis in vivo.
  • miR-497 directly targeted and inhibited eukaryotic translation initiation factor 4E (eIF4E) expression at mRNA and protein levels.
  • A negative correlation between miR-497 and eIF4E expression was observed in GC tissues.

Conclusions:

  • miR-497 functions as a tumor suppressor in gastric cancer progression.
  • miR-497 inhibits GC by downregulating eIF4E.
  • miR-497 represents a potential therapeutic target for gastric cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K